EKF Diagnostics to exhibit two POC testing analyzers for diabetes management at Arab Health

HbA1c and ß-HB analyzers enable rapid assessment of diabetes and related conditions

EKF Diagnostics, the global in vitro diagnostics business, will be exhibiting two newly introduced point-of-care (POC) testing analyzers for rapid assessment of diabetes and related conditions. The Quo-Lab glycated haemoglobin (HbA1c) analyzer and STAT-Site M ß-HB will both be demonstrated on the Welsh Assembly Government Stand Z1D30 in Zabeel Hall 1, Arab Health, Dubai International Convention & Exhibition Centre, 27 - 30 January 2014.

Although only launched in July 2012, close to 1,300 Quo-Lab HbA1c analyzers were sold globally in 2013, 60 of which are now installed in Lebanon for near-patient measurement and monitoring of diabetes. HbA1c monitoring is increasingly used in the detection and management of diabetes and the Quo-Lab provides highly accurate, affordable and easy-to-use technology, which uses just 4 µL of venous or finger prick blood to deliver lab-accurate results within four minutes. 

The STAT-Site M ß-HB analyzer from EKF Diagnostics

Small and lightweight, Quo-Lab is designed specifically to meet the needs of clinics and laboratories in emerging economies, where diabetes is an increasingly large public health issue, and is ideal for GP surgeries, diabetes clinics and laboratories.

EKF’s new STAT-Site M ß-HB will also be available for demonstrations. This new quantitative strip-based test for ß-Hydroxybutyrate (ß-HB) is CE marked and provides a quick and easy assessment of diabetic ketoacidosis (DKA), delivering results in less than 80 seconds. 

Using the STAT-Site M ß-HB, the presence and degree of ketosis can be rapidly assessed at the point-of-care by accurately measuring blood levels of ß-HB, which accounts for 78% of the three ketone bodies, from just 10 µL of serum or plasma. This provides useful information to provide quality care when monitoring DKA in newly diagnosed patients, whilst also reducing time and costs in an emergency room setting.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    EKF Diagnostics. (2014, August 15). EKF Diagnostics to exhibit two POC testing analyzers for diabetes management at Arab Health. News-Medical. Retrieved on May 24, 2019 from https://www.news-medical.net/news/20140108/EKF-Diagnostics-to-exhibit-two-POC-testing-analyzers-for-diabetes-management-at-Arab-Health.aspx.

  • MLA

    EKF Diagnostics. "EKF Diagnostics to exhibit two POC testing analyzers for diabetes management at Arab Health". News-Medical. 24 May 2019. <https://www.news-medical.net/news/20140108/EKF-Diagnostics-to-exhibit-two-POC-testing-analyzers-for-diabetes-management-at-Arab-Health.aspx>.

  • Chicago

    EKF Diagnostics. "EKF Diagnostics to exhibit two POC testing analyzers for diabetes management at Arab Health". News-Medical. https://www.news-medical.net/news/20140108/EKF-Diagnostics-to-exhibit-two-POC-testing-analyzers-for-diabetes-management-at-Arab-Health.aspx. (accessed May 24, 2019).

  • Harvard

    EKF Diagnostics. 2014. EKF Diagnostics to exhibit two POC testing analyzers for diabetes management at Arab Health. News-Medical, viewed 24 May 2019, https://www.news-medical.net/news/20140108/EKF-Diagnostics-to-exhibit-two-POC-testing-analyzers-for-diabetes-management-at-Arab-Health.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
EKF Diagnostics to showcase new Stanbio GA assay kit at AACC 2018